- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01427959
Tampere Traumatic Head and Brain Injury Study (TheBrainS)
October 5, 2021 updated by: Teemu Luoto, Tampere University Hospital
Tampere Traumatic head and brain injury study is a prospective study aiming to explore neuroradiological, neuropsychological, neurological and biochemical aspects of mild traumatic brain injury (mtbi).
The main interest is on factors that effect to the outcome after mtbi.
The study is conducted in Tampere University Hospital's emergency department between the 1st of August 2010 and 31st of July 2013.
Study Overview
Status
Completed
Conditions
Detailed Description
Aims of the study:
- To improve clinical assessment of mTBI in the acute phase
- To assemble better knowledge of diffusion tensor imaging as a diagnostic tool in mTBI
- To improve neuropsychological evaluation of mTBI Main focus on psychosocial functioning / outcome / correlates E.g. Resilience, PTSD
Study Type
Observational
Enrollment (Actual)
115
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tampere, Finland, 33521
- Tampere University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Community sample consisting of consecutive mild traumatic brain injury patients metting the enrollment criteria.
Description
Inclusion Criteria:
- WHO's mtbi criteria
- Inhabitant of Pirkanmaa hospital district
- Age between 18 and 60 years
Exclusion Criteria:
- Detrimental alcohol use
- Drug addiction
- Chronic neurological disease
- Earlier brain injury
- Diagnosed psychiatric disease
- Hearing or sight deficiency
- Native language other than finnish
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Teemu M. Luoto, M.D., Tampere University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2010
Primary Completion (ACTUAL)
February 1, 2021
Study Completion (ACTUAL)
February 1, 2021
Study Registration Dates
First Submitted
September 1, 2011
First Submitted That Met QC Criteria
September 1, 2011
First Posted (ESTIMATE)
September 2, 2011
Study Record Updates
Last Update Posted (ACTUAL)
October 6, 2021
Last Update Submitted That Met QC Criteria
October 5, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R10027
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.